Markers of Atrial Fibrillation

NCT02734758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2020-11-20

No results posted yet for this study

Summary

This study will evaluate whether a gene marker can improve the identification of atrial fibrillation in patients with ischemic stroke, and evaluate whether the decision to anticoagulate could be improved by a marker of atrial fibrillation.

Conditions

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2016-08-01
Completion
2020-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734758 on ClinicalTrials.gov